topic: Access to Medicines
MSF reveals cost of its landmark TB clinical trial: €34 million
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
Namrata’s journey: triumph over drug-resistant Tuberculosis
Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
MSF response to signing of EFTA-India trade agreement
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
